UC BON.CAP.CERT. 03/25 NESR/ DE000HD4ANM7 /
2024-10-08 9:45:49 PM | Chg.+0.560 | Bid9:59:38 PM | Ask- | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
82.730EUR | +0.68% | 82.690 Bid Size: 10,000 |
- Ask Size: - |
Nestle S.A. | - - | 2025-03-28 | Call |
GlobeNewswire
08-13
Seres Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Updates
GlobeNewswire
08-06
Seres Therapeutics Announces Signing of VOWST™ Asset Purchase Agreement with Nestlé Health Science
GlobeNewswire
07-23
Mondelēz International Names Filippo Catalano Chief Information and Digital Officer
GlobeNewswire
06-12
NFWF Announces $10.2 Million in Grants to Cultivate Conservation Practices on Agricultural Lands
GlobeNewswire
06-06
Seres Therapeutics Enters Into Memorandum of Understanding For Vowst™ Asset Sale to Nestlé Health Sc...
GlobeNewswire
05-08
WalkMe Announces Date of First Quarter 2024 Financial Results and Conference Call
GlobeNewswire
03-26
NESTLE INTERNATIONAL AWARDED OMNIQ A PURCHASE ORDER FOR THE SUPPLY OF RUGGEDIZED IOT EQUIPMENT TO NE...
GlobeNewswire
03-19
VML Augments Digital Commerce Capabilities by Forging Partnership with CommerceIQ’s Unified Artifici...